Assoc Professor James Wilmott

Bsc(Hons) PhD

Senior Scientist

Assoc Professor Wilmott has worked at Melanoma Institute Australia since 2008, where he joined the BioSpecimen Bank team. He went onto complete his PhD in 2013 which was entitled "Biology and biomarkers of BRAF mutant, BRAF inhibitor treated metastatic melanoma". He has published over 30 manuscripts which have been cited over 364 times, 245 citations were in 2013 alone (H-index 13). His research interests are biomarker studies of patients treated with targeted therapies and he is currently working as the project manager for the Australian Melanoma Genome Project.